Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRDM13 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | RARA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | LRP8 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | NCF1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | CD33 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | UNC5A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | NUFIP2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | CACNB4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | FHDC1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | SLC22A24 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |